Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
ATEC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Alphatec Holdings, Inc.
From Kirby McInerney LLP
Via GlobeNewswire
Tickers ATEC
News headline image
POET SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of POET Technologies Inc. Investors - Contact Kirby McInerney LLP by June 29, 2026
From Kirby McInerney LLP
Via GlobeNewswire
Tickers POET
News headline image
EMGA arranges USD 15m financing for Asia Alliance Bank from OeEB
From Emerging Markets Global Advisory
Via GlobeNewswire
News headline image
CLARITEV STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. is Investigating Claritev Corporation on Behalf of Claritev Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers CTEV
News headline image
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
From Denali Therapeutics Inc.
Via GlobeNewswire
Tickers BIIB DNLI
News headline image
Samba TV Launches Project Gravity, an Independent Data Activation Platform for the Agentic Era
From Samba TV
Via GlobeNewswire
News headline image
nVent to Participate in Upcoming Investor Conference
From nVent
Via GlobeNewswire
Tickers NVT
News headline image
YORK SPACE SYSTEMS INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating York Space Systems Inc. on Behalf of York Space Systems Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers YSS
News headline image
Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
From Crescent Biopharma, Inc.
Via GlobeNewswire
Tickers CBIO
News headline image
Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
From Pliant Therapeutics, Inc.
Via GlobeNewswire
Tickers PLRX
News headline image
BLACK ROCK COFFEE BAR ALERT: Bragar Eagel & Squire, P.C. is Investigating Black Rock Coffee Bar, Inc. on Behalf of Black Rock Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers BRCB
News headline image
Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors
From Aktis Oncology Inc.
Via GlobeNewswire
Tickers AKTS
News headline image
COMMVAULT INVESTOR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Commvault Systems, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers CVLT
News headline image
SPORTRADAR LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Sportradar Group AG and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers SRAD
News headline image
Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
Tickers BDTX
News headline image
Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026
From Autolus Therapeutics plc
Via GlobeNewswire
Tickers AUTL
News headline image
Equus Announces First Quarter Net Asset Value
From Equus Total Return, Inc
Via GlobeNewswire
Tickers EQS
News headline image
ROSEN, THE FIRST FILING FIRM, Encourages SES AI Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SES
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers SES
News headline image
Whale Dynamic Joins Hitch Open World AI Championships as Official Mapping Technology Partner, Delivering Centimeter-Accurate HD Map of Tianmen Mountain for 2026 Racing Season
From Hitch Interactive
Via GlobeNewswire
News headline image
North American Construction Group Ltd. Announces Voting Results of Annual and Special Meeting of Shareholders
From North American Construction Group Ltd.
Via GlobeNewswire
Tickers NOA TSX:NOA
News headline image
Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology
From Eikon Therapeutics, Inc.
Via GlobeNewswire
Tickers EIKN
News headline image
Remix Therapeutics Announces Positive Data from Phase 1/2 ARIA Study of First-in-Class MYB mRNA Degrader, REM-422, in Patients with Adenoid Cystic Carcinoma (ACC) at the American Society of Clinical Oncology Annual Meeting 2026
From Remix Therapeutics
Via GlobeNewswire
News headline image
Lynozyfic® (linvoseltamab) Monotherapy Demonstrates Deep and Rapid Responses in All Treated Patients with Second-Line-Plus Systemic Amyloid Light Chain Amyloidosis
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers REGN
News headline image
Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data
From Syndax Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SNDX
News headline image
AerSale Announces Participation at the 2026 Jefferies Aftermarket MRO Virtual Summit
From AerSale Inc
Via GlobeNewswire
Tickers ASLE
News headline image
Legend Biotech Announces Presentations at ASCO 2026
From Legend Biotech USA Inc.
Via GlobeNewswire
Tickers LEGN
News headline image
Navient declares second quarter common stock dividend
From Navient Corporation
Via GlobeNewswire
Tickers NAVI
News headline image
Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy
From Immuneering Corporation
Via GlobeNewswire
Tickers IMRX
News headline image
Asher Biotherapeutics Announces Two Presentations at the ASCO 2026 Annual Meeting Highlighting Clinical Progress Across Its CD8-Targeted Cytokine Pipeline
From Asher Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC
From Bicara Therapeutics Inc.
Via GlobeNewswire
Tickers BCAX
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.